NF-κB-mediated miR-30b regulation in cardiomyocytes cell death by targeting Bcl-2. (Q53084627)

11 May 2018

title

NF-κB-mediated miR-30b regulation in cardiomyocytes cell death by targeting Bcl-2. (English)

1 reference

11 May 2018

0 references

1 reference

Chuanyu Wei

1

1 reference

11 May 2018

Li Li

series ordinal

2

1 reference

11 May 2018

Sudhiranjan Gupta

series ordinal

3

1 reference

11 May 2018

publication date

1 November 2013

1 reference

11 May 2018

Molecular and Cellular Biochemistry

published in

1 reference

11 May 2018

volume

387

1 reference

11 May 2018

issue

1-2

1 reference

11 May 2018

page(s)

135-141

1 reference

11 May 2018

cites work

Apoptosis in the heart.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1878-1

Death by design. Programmed cell death in cardiovascular biology and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1878-1

Heat shock protein 90 regulates IκB kinase complex and NF-κB activation in angiotensin II-induced cardiac cell hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1878-1

Involvement of apoptosis signal-regulating kinase-1 on angiotensin II-induced monocyte chemoattractant protein-1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1878-1

Cardiomyocyte-specific IκB kinase (IKK)/NF-κB activation induces reversible inflammatory cardiomyopathy and heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1878-1

NF-kappaB activation is required for adaptive cardiac hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1878-1

Role of nuclear factor kappaB in cardiovascular health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1878-1

Activation of nuclear factor-kappaB is necessary for myotrophin-induced cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1878-1

Prevention of cardiac hypertrophy and heart failure by silencing of NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1878-1

Blockade of NF-kappaB using IkappaB alpha dominant-negative mice ameliorates cardiac hypertrophy in myotrophin-overexpressed transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1878-1

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1878-1

Transcription and processing of human microRNA precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1878-1

Emerging role of microRNAs in cardiovascular biology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1878-1

MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1878-1

MicroRNA-133 controls cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1878-1

Role of microRNAs in cardiac remodeling and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1878-1

Widespread microRNA repression by Myc contributes to tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1878-1

Trastuzumab produces therapeutic actions by upregulating miR-26a and miR-30b in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1878-1

MicroRNA-30b-5p is involved in the regulation of cardiac hypertrophy by targeting CaMKIIδ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1878-1

The microRNA-30 family targets DLL4 to modulate endothelial cell behavior during angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1878-1

Thymosin beta 4 protects cardiomyocytes from oxidative stress by targeting anti-oxidative enzymes and anti-apoptotic genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1878-1

NF-κB mediated miR-26a regulation in cardiac fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1878-1

Apoptosis: a potentially reversible, meta-stable state of the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1878-1

Angiotensin II stimulates apoptosis via TGF-beta1 signaling in ventricular cardiomyocytes of rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1878-1

MicroRNAs in cardiac remodeling and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1878-1

MicroRNAs in cardiac apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1878-1

Diagnostic and therapeutic potentials of microRNAs in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1878-1

Binding of NF-kappaB p65 subunit to the promoter elements is involved in LPS-induced transactivation of miRNA genes in human biliary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1878-1

A functional genomics screen for microRNA regulators of NF-kappaB signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1878-1

MicroRNAs in NF-kappaB signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1878-1

MicroRNA-30e* promotes human glioma cell invasiveness in an orthotopic xenotransplantation model by disrupting the NF-κB/IκBα negative feedback loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1878-1

Microarray analysis of H2O2-, HNE-, or tBH-treated ARPE-19 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1878-1

Nitric oxide donors protect murine myocardium against infarction via modulation of mitochondrial permeability transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1878-1

BCL2A1: the underdog in the BCL2 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1878-1

Transcriptional regulation of bcl-2 by nuclear factor kappa B and its significance in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1878-1

Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1878-1

Targeted deletion of nuclear factor kappaB p50 enhances cardiac remodeling and dysfunction following myocardial infarction

21 January 2018

1 reference

12 December 2020

Programmed myocyte cell death affects the viable myocardium after infarction in rats

1 reference

12 December 2020

Angiotensin II activates programmed myocyte cell death in vitro

1 reference

12 December 2020

Apoptosis in the failing human heart

1 reference

12 December 2020

Anti-apoptotic function of a microRNA encoded by the HSV-1 latency-associated transcript

1 reference

12 December 2020

Neurohormonal regulation of myocardial cell apoptosis during the development of heart failure

1 reference

12 December 2020

Angiotensin II induces nuclear factor- kappa B activation in cultured neonatal rat cardiomyocytes through protein kinase C signaling pathway

1 reference

12 December 2020

10.1007/S11010-013-1878-1

Identifiers

DOI

1 reference

11 May 2018

1 reference

11 May 2018